Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jiangsu Cai Qin Technology
688182
5
Dalian Dalicap Technology
301566
CN Stock MarketDetailed Quotes
300294 China Resources Boya Bio-pharmaceutical Group
- 27.49
- -0.72-2.55%
Market Closed Apr 18 15:00 CST
13.86BMarket Cap34.93P/E (TTM)
28.31High27.20Low85.31KlotVolume28.02Open28.21Pre Close235.47MTurnover1.69%Turnover Ratio34.93P/E (Static)504.25MShares41.8252wk High1.85P/B13.86BFloat Cap26.7652wk Low33.85Limit Up504.25MShs Float57.28Historical High22.57Limit Down3.94%Amplitude3.34Historical Low0.46Dividend TTM27.60Avg Price50.79KlotAsk1.67%Div YieldTTM100Lot Size31.31KlotBid
About China Resources Boya Bio-pharmaceutical Group Company
The company was founded in 1993. It is a blood products platform in China Resources Health. It is a comprehensive pharmaceutical industry group focusing on blood products business, integrating biochemicals, chemicals, APIs, etc., and is one of the few enterprises with a complete range of products in the three categories of human blood albumin, human immunoglobulins, and coagulation factors in the country. The company's business is mainly blood products, supplemented by biochemicals, chemicals, and APIs. The company's products cover products such as albumin, immunoglobulin, coagulation factors, compound osteopeptide injections, oxytocin injections, heparin sodium injections, posterior pituitary injections, and caprost tromethanol injections. Corporate honors: It has successively won honorary awards such as Forbes China's Top 100 Potential Listed Companies in 2013, 2014 and 2016, China's Top 50 Listed Companies in 2014, China's Top 100 Listed Companies Most Respected by Investors in 2015, China's Top 150 Listed Companies by Jinniu Value Investors in 2016, and Top 10 Pharmaceutical Companies with the Most Investment Value in 2017.
Company Profile
Short Name-A博雅生物
Symbol-A300294
Company NameChina Resources Boya Bio-pharmaceutical Group Co., Ltd
Listing DateMar 8, 2012
Issue Price25.00
Shares Offered19.02M share(s)
FoundedNov 6, 1993
Legal Representativexiaoming liang
General Managerxiaoming liang
Secretaryhuacheng liang
Accounting FirmKPMG Huazhen Certified Public Accountants (Special General Partnership)
Securities Representativedongke peng
Legal CounselBeijing Dacheng Law Firm
Employees632
Phone0794-8264398
Office AddressNo. 333 Huiquan Road, Fuzhou High-tech Industrial Development Zone, Jiangxi
Zip Code344000
Registered Address333 Huiquan Road, Fuzhou High-tech Industrial Development Zone, Fuzhou City, Jiangxi Province
Fax0794-8237323
Emaildongmi@china-boya.com
Websitehttps://www.china-boya.com
Business License361000110000915
BusinessLicense projects: pharmaceutical production, pharmaceutical contract production, pharmaceutical import/export, import and export of technology, import/export of goods, sales of pharmaceutical raw materials, excipients, intermediate products, production and sales of Class I and Class II medical devices (projects subject to approval according to law, business activities can only be carried out after approval by relevant departments); general projects: technical services, technology development, technical consultation, technical exchange, technology transfer, technology promotion, social and economic consulting services, marketing planning, financial consulting (in addition to licensed business, you can independently operate projects not prohibited or restricted by laws and regulations). (The details are subject to approval by the competent department of market supervision).
Company Executives
- Name
- Position
- Salary
- kai qiu
- Chairman, Directors, Member of the Nomination, Remuneration and Assessment Committee, Strategy and ESG Committee Member
- --
- xiaohui yu
- Directors, Strategy and ESG Committee Member
- --
- hui ren
- Directors, VP, Strategy and ESG Committee Member
- 93.00K
- huacheng liang
- Directors, Board Secretary, Deputy General Manager, Chief Financial Officer
- 1.11M
- xiaoming liang
- Directors, General Manager, Strategy and ESG Committee Member
- 2.99M
- yuxuan pan
- Directors, Audit Committee Member
- --
- weidong zhang
- Independent Directors, Audit Committee Convener, Member of the Nomination, Remuneration and Assessment Committee
- 200.00K
- li zhao
- Independent Directors, Strategy and ESG Committee Member, Audit Committee Member
- 200.00K
- huasheng huang
- Independent Directors, Nomination, Remuneration and Assessment Committee Convener
- 200.00K
- dongke peng
- Securities Affairs Representative
- --
- jiao zhou
- Chairman of the Supervisory Board, Auditors
- --
- guiling tan
- Auditors
- --
- shuanhong zhang
- VP
- 1.30M
- shousun li
- Deputy General Manager
- 1.86M
- bing chen
- Deputy General Manager
- 1.77M
- kaiheng han
- Head of Internal Audit
- --
- qianqian yan
- Employee Supervisors
- 46.00K
Market Insights
Discussing
Gold price hits new high! Safe havens in a turbulent market?
🎙️Discussion 1. The spot gold price has soared to a new high, with numerous institutions raising their gold price forecasts, would you be m
Riddick705
Apr 9 22:07
Dont Get Smoked!